A patient with MDR-TB receives bedaquiline, one of the first new TB medicines in nearly 50 years, at the start of the endTB clinical trial in Almaty, Kazakhstan. (Photo by Yekaterina Sahabutdinova / PIH)

Groundbreaking Kazakhstan TB Trial Continuing Amid COVID-19 Challenges

Despite Kazakhstan’s nationwide lockdown that began in March to contain COVID-19, Partners In Health clinicians have continued to examine and provide treatment—in person and online—for tuberculosis patients enrolled in a groundbreaking clinical trial. Clinicians have had to communicate regularly with police to cross checkpoints and have used their own vehicles Read more…